Prevention of asprin-induced small-intestinal injury by Poraprezinc
Not Applicable
- Conditions
- small-intestinal injury
- Registration Number
- JPRN-UMIN000003687
- Lead Sponsor
- Department of Endoscopy, Hiroshima University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients with inflammatory bowel disease 2. Patients with digestion and absorption disorder 3. Patients who is taking Poraprezinc 4. Patients who is taking other medicines for gastritis, such as Misoprostol, Rebamipide, etc. 5. Patients who is taking Penicillamine and Levothyroxine sodium 6. Patients with stenosis of gastrointestinal tract and severe adhesion 7. Pregnant and nursing women 8. Patients with severe ulcerative lesion with capsule endoscopy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Incidence of asprin-induced small-intestinal injury (redness, erosion, ulcer) 2. Evaluation of endoscopic findings with capsule endoscopy after taking Poraprezinc or not.
- Secondary Outcome Measures
Name Time Method